BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22284136)

  • 1. Preference-based measures in dermatology: an overview of utilities and willingness to pay.
    Seidler AM; Kini SP; DeLong LK; Veledar E; Chen SC
    Dermatol Clin; 2012 Apr; 30(2):223-9, xiii. PubMed ID: 22284136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preference quality of life measures in dermatology.
    McCombs K; Chen SC
    Dermatol Ther; 2007; 20(2):102-9. PubMed ID: 17537138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay in dermatology: assessment of the burden of skin diseases.
    Seidler AM; Bayoumi AM; Goldstein MK; Cruz PD; Chen SC
    J Invest Dermatol; 2012 Jul; 132(7):1785-90. PubMed ID: 22418874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A catalog of dermatology utilities: a measure of the burden of skin diseases.
    Chen SC; Bayoumi AM; Soon SL; Aftergut K; Cruz P; Sexton SA; McCall CO; Goldstein MK
    J Investig Dermatol Symp Proc; 2004 Mar; 9(2):160-8. PubMed ID: 15083784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study.
    Schmitt J; Meurer M; Klon M; Frick KD
    Br J Dermatol; 2008 Feb; 158(2):351-9. PubMed ID: 18070214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using willingness to pay to measure family members' preferences in mental health.
    Mulvaney-Day NE
    J Ment Health Policy Econ; 2005 Jun; 8(2):71-81. PubMed ID: 15998979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of health status quality-of-life measures.
    Kini SP; DeLong LK
    Dermatol Clin; 2012 Apr; 30(2):209-21, xiii. PubMed ID: 22284135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between utility values and willingness to pay in patients undergoing orthognathic treatment.
    Cunningham SJ; Hunt NP
    Community Dent Health; 2000 Jun; 17(2):92-6. PubMed ID: 11349993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
    Gafni A
    Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
    Blumenschein K; Johannesson M
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):189-94. PubMed ID: 9494453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future directions in dermatology quality of life measures.
    DeLong LK; Chen SC
    Dermatol Clin; 2012 Apr; 30(2):343-7, x. PubMed ID: 22284148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay per quality-adjusted life year: is one threshold enough for decision-making?: results from a study in patients with chronic prostatitis.
    Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
    Med Care; 2011 Mar; 49(3):267-72. PubMed ID: 21224742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in dermatology: introduction and overview.
    Chen SC
    Dermatol Clin; 2012 Apr; 30(2):205-8, xiii. PubMed ID: 22284134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
    Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
    Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to pay for a QALY.
    Gyrd-Hansen D
    Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating patient preferences with health utilities: a variation on health-related quality of life.
    VanBeek MJ
    Arch Dermatol; 2008 Aug; 144(8):1037-41. PubMed ID: 18711078
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems.
    Rogers A; DeLong LK; Chen SC
    Dermatol Clin; 2012 Apr; 30(2):333-42, x. PubMed ID: 22284147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The practical reality of using a patient-reported outcome measure in a routine dermatology clinic.
    Salek S; Roberts A; Finlay AY
    Dermatology; 2007; 215(4):315-9. PubMed ID: 17911989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.